SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-07-013584
Filing Date
2007-06-19
Accepted
2007-06-18 20:15:31
Documents
6
Period of Report
2007-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d47619e8vk.htm 8-K 27110
2 AMENDMENT TO EMPLOYMENT AGREEMENT - KENNETH J. COLLINS d47619exv10w1.htm EX-10.1 18054
3 AMENDMENT TO EMPLOYMENT AGREEMENT - ROGER ECHOLS, M.D. d47619exv10w2.htm EX-10.2 17393
4 AMENDMENT TO EMPLOYMENT AGREEMENT - MARK SMITH d47619exv10w3.htm EX-10.3 18253
5 AMENDMENT TO EMPLOYMENT AGREEMENT - NEBOJSA JANJIC, PH.D. d47619exv10w4.htm EX-10.4 18992
6 AMENDMENT TO EMPLOYMENT AGREEMENT - PETER LETENDRE, PHARM.D. d47619exv10w5.htm EX-10.5 17447
  Complete submission text file 0000950134-07-013584.txt   118800
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 303-665-3450
REPLIDYNE INC (Filer) CIK: 0001180145 (see all company filings)

IRS No.: 841568247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52082 | Film No.: 07927090
SIC: 2834 Pharmaceutical Preparations